Clinical Trials in Boston

Showing 9081-9100 of 13,548 trials

Serious Illness Communication Project

NCT01786811

The purpose of the study is to evaluate the impact of implementing a "Serious Illness Conversation Guide" to guide patient/family-clinician discussions and planning about end-of-life care decisions. The goal of the intervention is to improve achievement of patient care priorities and peacefulness at the end of life for patients with serious and life-threatening illness and their families. We hypothesize that patients whose physician is trained to use and adheres to the elements of the Serious Illness Conversation Guide will demonstrate enhanced consistency between documented key priorities and care received, and will experience greater peace in the final month of life; similarly, their families will experience higher satisfaction with care.

End of Life CareCancer

Dana-Farber Cancer Institute994 participantsStarted Jun 2012

Boston, Massachusetts, United States

TERMINATEDPhase 2< 1 mile

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

NCT01497665

The purpose of this study is to assess the efficacy, safety, and tolerability of GRN1005 in patients with brain metastases from non-small cell lung cancer (NSCLC).

Non-small Cell Lung Cancer (NSCLC) With Brain Metastases

Angiochem Inc16 participantsStarted Nov 2011

La Jolla, California, United States • Aurora, Colorado, United States • Tampa, Florida, United States +7 more locations

Serious Illness Communication Project

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Find Trials by Condition in Boston

Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing

Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee OA?

High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)

Comparison of Ultrasound Guided Peripheral IV Placement With and Without Use of a Guidewire

Written Exposure Therapy for Posttraumatic Stress Disorder

D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

Preoperative Herceptin and Navelbine for Breast Cancer

A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2

Cyclophosphamide and Alemtuzumab In Lymphoma

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Adjunctive Psychotherapy for Perinatal Bipolar Disorder

Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib

Detection of Cytomegalovirus Virus in Neonates